Hologic [HOLX] vs Becton, Dickinson [BDX] Detailed Stock Comparison

Hologic Inc.

NASDAQ
Loading...

Becton, Dickinson and Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Hologic Inc. wins in 9 metrics, Becton, Dickinson and Company wins in 11 metrics, with 0 ties. Becton, Dickinson and Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Hologic Inc. Becton, Dickinson and Company Better
P/E Ratio (TTM) 31.54 25.40 Becton, Dickinson and Company
Price-to-Book Ratio 3.23 1.75 Becton, Dickinson and Company
Debt-to-Equity Ratio 48.05 77.28 Hologic Inc.
PEG Ratio -3.92 0.92 Becton, Dickinson and Company
EV/EBITDA 12.68 10.49 Becton, Dickinson and Company
Profit Margin (TTM) 13.18% 8.01% Hologic Inc.
Operating Margin (TTM) 22.99% 13.35% Hologic Inc.
EBITDA Margin (TTM) 22.99% 13.35% Hologic Inc.
Return on Equity 10.86% 6.96% Hologic Inc.
Return on Assets (TTM) 7.43% 4.08% Hologic Inc.
Free Cash Flow (TTM) $904.70M $2.67B Becton, Dickinson and Company
Dividend Yield N/A 2.56% N/A
1-Year Return 31.39% 8.01% Hologic Inc.
Price-to-Sales Ratio (TTM) 4.11 2.57 Becton, Dickinson and Company
Enterprise Value $17.12B $63.40B Becton, Dickinson and Company
EV/Revenue Ratio 4.15 2.89 Becton, Dickinson and Company
Gross Profit Margin (TTM) 55.96% 45.91% Hologic Inc.
Revenue per Share (TTM) $18 $76 Becton, Dickinson and Company
Earnings per Share (Diluted) $2.41 $6.13 Becton, Dickinson and Company
Beta (Stock Volatility) 0.70 0.35 Becton, Dickinson and Company
Short % of Float 3.66% 3.78% Hologic Inc.

Hologic Inc. vs Becton, Dickinson and Company Stock Performance Analysis

Loading Price Chart...

HOLX
BDX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hologic Inc.0.00%0.56%0.56%1.40%12.23%1.94%
Becton, Dickinson and Company-0.49%-2.98%1.43%-9.20%-7.49%-5.04%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hologic Inc.31.39%-9.66%-0.85%110.15%246.29%206.74%
Becton, Dickinson and Company8.01%-28.08%-20.73%15.00%123.99%212.28%

Performance & Financial Health Analysis: Hologic Inc. vs Becton, Dickinson and Company

MetricHOLXBDX
Market Information
Market Cap i$16.97B$56.10B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i12,273,0852,759,250
90 Day Avg. Volume i6,282,6252,521,130
Last Close$76.01$145.52
52 Week Range$51.90 - $76.07$127.59 - $187.35
% from 52W High-0.08%-22.33%
All-Time High$87.88 (May 01, 2023)$287.32 (Jul 24, 2023)
% from All-Time High-13.51%-49.35%
Growth Metrics
Quarterly Revenue Growth0.03%0.02%
Quarterly Earnings Growth-0.11%0.26%
Financial Health
Profit Margin (TTM) i0.13%0.08%
Operating Margin (TTM) i0.23%0.13%
Return on Equity (TTM) i0.11%0.07%
Debt to Equity (MRQ) i48.0577.28
Cash & Liquidity
Book Value per Share (MRQ)$23.51$88.79
Cash per Share (MRQ)$10.60$2.64
Operating Cash Flow (TTM) i$1.10B$3.39B
Levered Free Cash Flow (TTM) i$848.61M$3.11B
Dividends
Last 12-Month Dividend Yield iN/A2.56%
Last 12-Month Dividend iN/A$4.18

Valuation & Enterprise Metrics Analysis: Hologic Inc. vs Becton, Dickinson and Company

MetricHOLX (Apr 19, 2026)BDX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i31.5425.40
Forward P/E i15.6411.53
PEG Ratio i-3.920.92
Price to Sales (TTM) i4.112.57
Price to Book (MRQ) i3.231.75
Market Capitalization
Market Capitalization i$16.97B$56.10B
Enterprise Value i$17.12B$63.40B
Enterprise Value Metrics
Enterprise to Revenue i4.152.89
Enterprise to EBITDA i12.6810.49
Risk & Other Metrics
Beta i0.700.35
Book Value per Share (MRQ) i$23.51$88.79

Financial Statements Comparison: Hologic Inc. vs Becton, Dickinson and Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHOLX (2025)BDX (2025)
Revenue/Sales i4.10B21.84B
Cost of Goods Sold i1.98B11.92B
COGS % of Revenue i48.4%54.6%
Gross Profit i2.12B9.93B
Gross Margin i51.6%45.4%
Research & Development i248.20M1.27B
Operating Income (EBIT) i785.40M2.99B
Operating Margin i19.2%13.7%
EBITDA i1.17B5.42B
EBITDA Margin i28.5%24.8%
Pre-Tax Income i681.20M1.88B
Pre-Tax Income % of Revenue i16.6%8.6%
Income Tax i115.50M203.00M
Income Tax % of Revenue i2.8%0.9%
Net Income (Profit) i565.70M1.68B
Profit Margin i13.8%7.7%

Balance Sheet & Liquidity Metrics

MetricHOLX (2025)BDX (2025)
Cash & Equivalents i1.96B641.00M
Total Current Assets i3.67B9.26B
Total Current Assets % of Revenue i89.5%42.4%
Total Current Liabilities i977.20M8.31B
Total Current Liabilities % of Revenue i23.8%38.1%
Long-Term Debt i2.59B17.62B
Long-Term Debt % of Revenue i63.2%80.7%
Total Shareholders Equity i5.05B25.39B
Retained Earnings i3.41B16.62B
Retained Earnings % of Revenue i83.2%76.1%
Property, Plant & Equipment i1.07B0

Cash Flow Statement Comparison

MetricHOLX (2025)BDX (2025)
Operating Cash Flow i831.50M3.68B
Operating Cash Flow % of Revenue i20.3%16.9%
Capital Expenditures i-78.20MN/A
Free Cash Flow i904.70M2.67B
FCF Margin i22.1%12.2%
Debt Repayment i-1.20B-1.79B
Common Stock Repurchase i-752.90MN/A

Short Interest & Institutional Ownership Analysis

MetricHOLXBDX
Shares Short i7.10M9.49M
Short Ratio i2.783.92
Short % of Float i3.66%3.78%
Shares Outstanding i223.07M284.74M
Float Shares i221.21M283.99M
% Held by Insiders i0.84%0.40%
% Held by Institutions i96.52%96.58%
% Held by Public i2.64%3.02%

Dividend Analysis & Yield Comparison: Hologic Inc. vs Becton, Dickinson and Company

MetricHOLXBDX
Last 12-Month Dividend iN/A$4.18
Last 12-Month Dividend Yield iN/A2.56%
3-Year Avg Annual Dividend iN/A$3.96
3-Year Avg Dividend Yield iN/A0.58%
3-Year Total Dividends iN/A$11.88
Ex-Dividend DateN/AMar 10, 2026